Nicole Keith

Director/Board Member presso SANA BIOTECHNOLOGY, INC.

Health Technology

Profilo

Nicole Keith is currently working as an Investor Relations Contact at Juno Therapeutics, Inc. since 2015.
She is also currently working as an Investor Relations & Media professional at Sana Biotechnology, Inc. Additionally, Ms. Keith previously worked as the Head-Investor Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.

Posizioni attive di Nicole Keith

Società	Posizione	Inizio
JUNO THERAPEUTICS INC	Investor Relations Contact	01/07/2015
SANA BIOTECHNOLOGY, INC.	Director/Board Member	-

Tutte le posizioni attive di Nicole Keith

Precedenti posizioni note di Nicole Keith

Società	Posizione	Fine
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Public Communications Contact	01/12/2013

Vedi nel dettaglio l'esperienza di Nicole Keith

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nicole Keith

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SANA BIOTECHNOLOGY, INC.	Health Technology

Aziende private	2
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Health Technology
Juno Therapeutics, Inc. Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA.	Health Technology